NFA
REGN icon

Nationwide Fund Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Nationwide Fund Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-74,885
Closed -$33.5M – 1631
2017
Q3 		$33.5M Sell
74,885
-2,944
-4% -$1.4M 0.13% 150
2017
Q2 		$38.2M Buy
77,829
+24,639
+46% +$10.8M 0.15% 115
2017
Q1 		$20.6M Sell
53,190
-2,261
-4% -$838K 0.08% 308
2016
Q4 		$20.4M Buy
55,451
+865
+2% +$329K 0.08% 296
2016
Q3 		$21.9M Buy
54,586
+11,910
+28% +$4.78M 0.09% 254
2016
Q2 		$14.9M Buy
42,676
+19,101
+81% +$7.36M 0.06% 411
2016
Q1 		$8.5M Sell
23,575
-7,413
-24% -$3.05M 0.04% 654
2015
Q4 		$16.8M Sell
30,988
-34,285
-53% -$18.6M 0.07% 350
2015
Q3 		$30.4M Buy
65,273
+1,134
+2% +$609K 0.14% 157
2015
Q2 		$32.7M Buy
64,139
+4,383
+7% +$2.14M 0.13% 156
2015
Q1 		$27M Sell
59,756
-1,551
-3% -$657K 0.11% 212
2014
Q4 		$25.2M Buy
61,307
+3,700
+6% +$1.46M 0.11% 218
2014
Q3 		$20.8M Sell
57,607
-5,600
-9% -$1.88M 0.09% 276
2014
Q2 		$17.9M Sell
63,207
-15,720
-20% -$4.66M 0.07% 332
2014
Q1 		$23.7M Buy
78,927
+8,308
+12% +$2.56M 0.11% 214
2013
Q4 		$19.4M Buy
70,619
+1,727
+3% +$497K 0.08% 299
2013
Q3 		$21.6M Buy
68,892
+35,920
+109% +$9.45M 0.1% 243
2013
Q2 		$7.42M Buy
+32,972
New +$7.68M 0.04% 606

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Nationwide Fund Advisors's REGN Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q4 2017, closing a stake of 74,885 shares — an estimated $33.5M sold.

Nationwide Fund Advisors first reported a position in REGN in Q2 2013 and held it in 18 quarters. The position peaked at $38.2M in Q2 2017. 639 funds tracked by Wall St. Rank hold REGN as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Regeneron Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 74,885 Regeneron Pharmaceuticals shares in Q4 2017, an estimated $33.5M.
  • Nationwide Fund Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Regeneron Pharmaceuticals position peaked at $38.2M in Q2 2017.
  • 639 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.